For research use only
| Cat No. | ABC-X0046C |
| Product Type | Overexpression Stable Cell Lines |
| Cell Type | Fibroblast |
| Species | Human |
| Host Cell | NIH/3T3 |
| Source Organ | Embryo |
| Disease | Normal |
| Storage | Liquid Nitrogen |
The human BRAF (G469A) NIH/3T3 cell line provides a reliable platform for tumor research, supporting high-throughput screening and BRAF-dependent studies.
Human BRAF (G469A) NIH/3T3 Cell Line is a genetically engineered model derived from murine NIH/3T3 fibroblasts based on customers’ requirement. BRAF (G469A) NIH/3T3 mutant cell line is created by stable integration of the human BRAF gene carrying the G469A mutation into NIH/3T3 cells using our proprietary lentiviral transduction approach.
Target
BRAF is a serine/threonine-protein kinase in the RAS-RAF-MEK-ERK signaling cascade. The G469A mutation, located in the activation segment of the kinase domain, enhances kinase activity and promotes tumorigenesis independent of upstream signals. It has been implicated in lung and colorectal cancers. AcceGen provides precise oncogenic models for pathway elucidation and drug testing. Polyclonal or monoclonal is optional based on customers’ research needs.
| Species | Human |
| Cat.No | ABC-X0046C |
| Product Category | Transfected Stable Cell Lines |
| Size/Quantity | 1 vial |
| Cell Type | Fibroblast |
| Growth Mode | Adherent |
| Shipping Info | Dry Ice |
| Growth Conditions | 37 °C, 5% CO₂ |
| Source Organ | Embryo |
| Disease | Normal |
| Biosafety Level | 1 |
| Storage | Liquid Nitrogen |
| Product Type | Overexpression Stable Cell Lines |
| Host Cell | NIH/3T3 |
| Quality Control | All cells test negative for mycoplasma, bacteria, yeast, and fungi. |
The BRAF (G469A) NIH/3T3 Cell Line serves as a reliable platform to assess BRAF-dependent transformation, MAPK pathway activation, and resistance to BRAF or MEK inhibitors. It is useful for preclinical studies and high-throughput screening of pathway-targeted therapies.